.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 8,933,039

« Back to Dashboard

Details for Patent: 8,933,039

Title:Glucagon-like peptide-2 analogs
Abstract: Analogs of glucagon-like peptide 2, a product of glucagon gene expression, have been identified as intestinal tissue growth factors. Their formulation as pharmaceutical, and therapeutic use in treating disorders of the small bowel, are described.
Inventor(s): Drucker; Daniel J (Toronto, CA), Crivici; Anna E. (San Diego, CA), Sumner-Smith; Martin (Bolton, CA)
Assignee: NPS Pharmaceuticals, Inc. (Bedminster, NJ) 1149336 Ontario Inc. (CA)
Filing Date:Jun 15, 2010
Application Number:12/816,312
Claims:1. An intestinotrophic GLP-2 analog, comprising SEQ ID NO: 2, wherein position 2 of SEQ ID NO: 2 consists of an amino acid other than Ala, positions 5-9, 11-18, and 21-23 of SEQ ID NO: 2 are unmodified, position 1 of SEQ ID NO: 2 optionally consists of an amino acid other than His; position 3 of SEQ ID NO: 2 optionally consists of an amino acid other than Asp; position 4 of SEQ ID NO: 2 optionally consists of an amino acid other than Gly; position 10 of SEQ ID NO: 2 optionally consists of an amino acid other than Met; position 19 of SEQ ID NO: 2 optionally consists of an amino acid other than Ala; position 20 of SEQ ID NO: 2 optionally consists of an amino acid other than Arg; and position 24 of SEQ ID NO: 2 optionally consists of an amino acid other than Asn.

2. A pharmaceutical composition comprising the GLP-2 analog of claim 1, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

3. The GLP-2 analog of claim 1, wherein the amino acid at position 1 is Tyr or Ala.

4. The GLP-2 analog of claim 1, wherein the amino acid at position 2 is one of the following: D-Ala, Gly, Val, t-Butyl-Gly, Asp, Glu, Phe, His, Ile, Lys, Met, Asn, Pro, Gln, Ser, Thr, Tyr, Pen, .beta.-Ala, .alpha.-Abu, Nval, PhGly, or Aib.

5. The GLP-2 analog of claim 1, wherein the amino acid at position 3 is Glu or Ala.

6. The GLP-2 analog of claim 1, wherein the amino acid at position 4 is Ala.

7. The GLP-2 analog of claim 1, wherein the amino acid at position 10 is one of the following: Val, Ile, Asn, Glu, Gln, Tyr, Phe, Leu, Nle, Ala, Ser, or Gly.

8. The GLP-2 analog of claim 1, wherein the amino acid at position 19 is Thr.

9. The GLP-2 analog of claim 1, wherein the amino acid at position 20 is Lys or Ala.

10. The GLP-2 analog of claim 1, wherein the amino acid at position 24 is Ala.

11. The GLP-2 analog of claim 1 wherein the amino acid at position 2 is Gly.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc